Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitochondrial processing peptidase is a heterodimer consisting of alpha-
mitochondrial processing peptidase
(alpha-MPP) and beta-
MPP
. We investigated the role of alpha-
MPP
in substrate recognition using a recombinant yeast
MPP
. Disruption of amino acid residues between 10 and 129 of the alpha-
MPP
did not essentially impair binding activity with beta-
MPP
and processing activity, whereas truncation of the C-terminal 41 amino acids led to a significant loss of binding and processing activity. Several acidic amino acids in the region conserved among the enzymes from various species were mutated to asparagine or glutamine, and effects on processing of the precursors were analyzed. Glu353 is required for processing of malate dehydrogenase,
aspartate aminotransferase
, and adrenodoxin precursors. Glu377 and Asp378 are needed only for the processing of
aspartate aminotransferase
and adrenodoxin precursors, both of which have a longer extension peptide than the others studied. However, processing of the yeast alpha-
MPP
precursor, which has a short extension peptide of nine amino acids, was not affected by these mutations. Thus, effects of substitution of acidic amino acids on the processing differed with the precursor protein and depended on length of the extension peptides. alpha-
MPP
may function as a substrate-recognizing subunit by interacting mainly with basic amino acids at a region distal to the cleavage site in precursors with a longer extension peptide.
...
PMID:Role of alpha-subunit of mitochondrial processing peptidase in substrate recognition. 973 75